FOR those of us who turn to science for answers, the Wuhan coronavirus outbreak is unsettling. We don\'t know what proportion of infected people are likely to die; our figures for how many other people on average each carrier infects are only estimates; and the total number of cases is likely to be far higher than those confirmed so far. These three parameters are crucial for epidemiologists who use models to calculate how bad an outbreak will get, but we don\'t yet know what values to punch into the models.

As cases in China soar, the list of unknowns gets even longer. It remains unclear whether the virus can spread before symptoms show. We don\'t yet know how or when the virus is likely to have crossed over from bats, or why the first known human case of the virus seems to have no connection to the Wuhan food market where the outbreak appears to have begun. Is every case equally infectious, or are some people unlikely to pass it on, while others act as super-spreaders? And is the virus only deadly for those who are older or who already have chronic conditions?

"If the virus goes global, it could one day resemble flu, which every year causes hundreds of thousands of deaths"

What we do know is that the outbreak is likely to go one of three ways. As this magazine went to press, the outbreak seemed on the verge of becoming a pandemic -- in which multiple epidemics of an infection take place across the world. From here, the virus may either peter out or go truly global. We can\'t know yet how many lives this would claim.

If it goes global, it could one day resemble flu, which every year causes an estimated 3 to 5 million cases of severe illness, and about 290,000 to 650,000 deaths. Flu can cause mild symptoms in some people and much worse ones in others, and most deaths occur in people over the age of 65 -- all of which may be true for the new coronavirus.

There is another option. The race is now on to find drugs and vaccines that could help bring the virus under control and prevent global exposure. While drug development will take time, trials of existing drugs are already under way in China. If successful, we may be able to save many lives -- although we can\'t yet calculate the number.
